Valuation: DexCom, Inc.

Market Cap 32.47B 164B 28.96B 26.84B 24.4B 45.8B 3,082B 46.52B 322B 126B 1,609B 122B 119B 5,147B P/E 2026 *
34.6x
P/E 2027 * 29.1x
Enterprise Value 31.71B 160B 28.28B 26.21B 23.83B 44.72B 3,009B 45.42B 314B 123B 1,572B 119B 116B 5,027B EV / Sales 2026 *
6.06x
EV / Sales 2027 * 5.42x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-7.95%
1 week-2.06%
Current month-3.92%
1 month-5.82%
3 months+17.88%
6 months+33.28%
Current year+14.42%
1 week 8.57
Extreme 8.57
8.75
1 month 8.16
Extreme 8.16
9.22
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-7.95%-2.06% - - 32.47B
-0.79%+4.48%-19.04%+8.89% 181B
-2.09%+4.85%-3.14%+27.61% 116B
+1.11%+7.43%-20.43%+10.27% 113B
-1.52%+3.89%-51.34%-7.07% 79.83B
-0.27%+4.99%+4.72%+79.37% 65.06B
-0.27%+2.10%+15.54%+66.81% 54.35B
-0.53%+3.80%+0.87%-26.47% 52.23B
-0.81%+7.30%-12.53%+30.68% 44.15B
-0.07%+2.22%+29.10%+2.21% 32.47B
Average -1.39%+5.18%-6.25%+21.37% 82.07B
Weighted average by Cap. -1.12%+5.50%-11.70%+19.30%

Financials

2026 *2027 *
Net sales 5.23B 26.38B 4.66B 4.32B 3.93B 7.38B 496B 7.49B 51.83B 20.36B 259B 19.62B 19.21B 829B 5.79B 29.22B 5.17B 4.79B 4.35B 8.17B 550B 8.3B 57.42B 22.55B 287B 21.74B 21.28B 918B
Net income 973M 4.91B 868M 804M 731M 1.37B 92.36B 1.39B 9.64B 3.79B 48.23B 3.65B 3.57B 154B 1.15B 5.78B 1.02B 947M 861M 1.62B 109B 1.64B 11.36B 4.46B 56.79B 4.3B 4.21B 182B
Net Debt -761M -3.84B -679M -629M -572M -1.07B -72.24B -1.09B -7.54B -2.96B -37.73B -2.86B -2.8B -121B -1.06B -5.35B -947M -877M -798M -1.5B -101B -1.52B -10.52B -4.13B -52.62B -3.98B -3.9B -168B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
85.98USD
Average target price
96.46USD
Spread / Average Target
+12.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.